Covid-19 roundup: FDA commissioners call for more ‘concerted effort’ on convalescent plasma R&D; Regeneron boosts case for antibody cocktail with new animal data

Jason Mast

Editor

Amber Tong

Four former FDA commissioners have coalesced around a century-old treatment they believe can give the best weapon against Covid-19: Convalescent plasma.

Writing in

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Covid-19 roundup: FDA commissioners call for more ‘concerted effort’ on convalescent plasma R&D; Regeneron boosts case for antibody cocktail with new animal data

Jason Mast

Editor

Amber Tong

Sign up to read this article for free.

RFK Jr. and Elon Musk want to ban pharma ads. They wouldn't be the first to try

Novartis seeks more bolt-on deals as it purchases neuro startup for up to $1.1B

FDA vaccine chief Peter Marks pledges to stay as long as he's welcome

Amgen names Stanford geneticist and biotech founder to CSO post

Caltech spinout debuts with AI-driven 'mirror peptide' platform

Are programs with compounded GLP-1s safe for your population?

Covid-19 roundup: FDA com­mis­sion­ers call for more ‘con­cert­ed ef­fort’ on con­va­les­cent plas­ma R&D; Re­gen­eron boosts case for an­ti­body cock­tail with new an­i­mal da­ta

Editor

Sign up to read this article for free.

Covid-19 roundup: FDA commissioners call for more ‘concerted effort’ on convalescent plasma R&D; Regeneron boosts case for antibody cocktail with new animal data